SCHEMBL28028310

SCHEMBL28028310

Nn1cccc1NC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28194790 0.74 — —
SCHEMBL28266002 0.74 — —
SCHEMBL27985186 0.71 ALDH1A1 (0.35) —
SCHEMBL28295721 0.68 ALDH1A1 (0.33) —
SCHEMBL1703803 0.65 — —
Pyridine SCHEMBL28875144 0.65 TRIM24 (0.39) —
SCHEMBL28302067 0.63 IDH1 (0.43) —
SCHEMBL12129057 0.59 ALDH1A1 (0.67) —
SCHEMBL28947850 0.58 ALDH1A1 (0.34) —
SCHEMBL27981770 0.58 ALDH1A1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108218874-B Phosphodiesterase inhibitor and application thereof 南京药捷安康生物科技有限公司 2020-10-30 — — CN disclosed
CN-104876935-B 2-aminopyrrolo[1,2-f][1,2,4]triazine compounds, and synthesis method and application thereof 南方医科大学 2017-04-19 — — CN disclosed
CN-104876935-A 2-aminopyrrolo[1,2-f][1,2,4]triazine compounds, and synthesis method and application thereof UNIV SOUTHERN MEDICAL 2015-09-02 — — CN disclosed
Send feedback